Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Intrust Bank NA

Intrust Bank NA reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the 4th quarter, Holdings Channel reports. The institutional investor owned 7,391 shares of the medical equipment provider’s stock after selling 41 shares during the quarter. Intrust Bank NA’s holdings in Intuitive Surgical were worth $2,493,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the business. Baystate Wealth Management LLC raised its holdings in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares during the last quarter. MCF Advisors LLC raised its holdings in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the last quarter. Atticus Wealth Management LLC raised its holdings in shares of Intuitive Surgical by 85.4% in the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 41 shares during the last quarter. OFI Invest Asset Management acquired a new position in shares of Intuitive Surgical in the third quarter worth $25,000. Finally, Headinvest LLC acquired a new position in shares of Intuitive Surgical in the third quarter worth $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ISRG. BTIG Research lifted their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Stifel Nicolaus boosted their price target on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Finally, Citigroup boosted their price target on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $396.17.

Insider Activity

In other news, SVP Mark Brosius sold 196 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at $736,800. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Intuitive Surgical news, President David J. Rosa sold 80,710 shares of the stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the completion of the transaction, the president now directly owns 163,399 shares of the company’s stock, valued at approximately $63,607,962.72. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 196 shares of the stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the sale, the senior vice president now owns 1,842 shares of the company’s stock, valued at approximately $736,800. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 225,093 shares of company stock valued at $87,153,299. 0.80% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 0.3 %

NASDAQ ISRG traded down $1.19 on Monday, hitting $374.14. 921,634 shares of the stock traded hands, compared to its average volume of 1,645,952. The stock has a 50-day moving average of $386.19 and a 200 day moving average of $346.74. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $403.76. The company has a market capitalization of $132.71 billion, a P/E ratio of 67.75, a price-to-earnings-growth ratio of 4.85 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business’s revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.00 earnings per share. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.